维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

8篇 您的检索式：作者名="Eric JC"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project 显示文摘	Esther AM Eric JC Van A	2006	Euro J Public Health2006，17，2：	1
	2	Effect of Calcium and Vitamin D Supplementation on Bone Mineral Density in Children With Inflammatory Bowel Disease显示文摘	Eric I Benchimol Leanne M Ward JC Gallagher Frank Rauch Nick Barrowman Jaime Warren Susan Beedle David R Mack	2007	Journal of Pediatric Gastroenterology and Nutrition2007，，5：	1
	3	MMP-2 expression by fibrob- lasts is suppressed by the myofibroblast phenotype 显示文摘	Eric WH Beverly JC Dawn LU	2012	Experimental Cell Research2012，318，13：	1
	4	Care of the liver transplant patient显示文摘	Eric RK Scott JC	2008	Dis Mon2008，54，：	1
	5	Chronic disease in the childhoodcancer survivor study cohort:A review of published findings显示文摘	Diller L Eric JC James G	2009	J ClinOncol2009，27，14：	1
	6	School closure and mitigation of pandemic(H1N1)2009,Hong Kong 显示文摘	Joseph TW Benjamin JC Eric HYL	2010	Emerg Infect Dis2010，16，：	1
	7	The effect of a low-carbohydrate,ketogenic diet versus a low-glycemic index diet on glycemic control in type 2diabetes mellitus显示文摘	Eric CW Yancy WS Mavropoulos JC	2008	Nutr Metab(Lond)2008，5，1：	1
	8	Cost-effectiveness in Clostridium difficile treatment decision-making显示文摘AIM: To develop a framework for the clinical and health economic assessment for management of Clostridium difficile infection(CDI).METHODS: CDI has vast economic consequences emphasizing the need for innovative and cost effective solutions, which were aim of this study. A guidance model was developed for coverage decisions and guideline development in CDI. The model included pharmacotherapy with oral metronidazole or oral vancomycin, which is the mainstay for pharmacological treatment of CDI and is recommended by most treatment guidelines.RESULTS: A design for a patient-based cost-effectiveness model was developed, which can be used to estimate the cost-effectiveness of current and future treatment strategies in CDI. Patient-based outcomes were extrapolated to the population by including factors like, e.g., person-to-person transmission, isolation precautions and closing and cleaning wards of hospitals. CONCLUSION: The proposed framework for a population-based CDI model may be used for clinical and health economic assessments of CDI guidelines and coverage decisions for emerging treatments for CDI.	Mark JC Nuijten Josbert J Keller Caroline E Visser Ken Redekop Eric Claassen Peter Speelman Marja H Pronk	2015	World Journal of Clinical Cases2015，3，11：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费